Home > Internet > Some Grotesque Actuality Relating To Your Lovely 17-AAG Imagination

Some Grotesque Actuality Relating To Your Lovely 17-AAG Imagination

Added: (Wed Sep 13 2017)

Pressbox (Press Release) - 45, 95% CI: 1.33 to 4.52, p?= 0.004). There was no difference in baseline levels of BNP between treatment arms (31 vs. 32 ng/l, p?= NS). When examined by elevated (>80 pg/ml) or normal (>80 pg/ml) baseline levels of BNP and treatment arm, patients with elevated baseline 17-AAG molecular weight levels (>80 pg/ml) of BNP randomized to pravastatin had the highest rate of hospitalization for HF (8.6%) followed by patients with an elevated BNP randomized to atorvastatin (4.1%), patients with normal BNP randomized to pravastatin (2.8%), and then patients normal baseline levels of BNP randomized to atorvastatin were at 1.8% (Fig.?2). Assignment to atorvastatin significantly reduced the risk of the development of HF among patients with elevated levels of BNP (HR: 0.50, 95% CI: 0.27 to 0.93, p?= 0.028). Although patients with such elevated levels of BNP had a greater absolute reduction in the risk of HF (4.5%) with intensive statin therapy than patients with low BNP (1.0%, HR: 0.72, 95% CI: 0.45 to 1.14, p?= 0.16), formal statistical testing for an interaction of BNP with the effect of treatment was not significant (p?interaction?= 0.36). A meta-analysis of the four published large, randomized trials that compared intensive statin therapy with moderate statin LGK974 therapy and that reported the rates of congestive HF demonstrates a highly significant 27% reduction in the odds of hospitalization for HF in (n?= 27,546, OR: 0.73, 95% CI: 0.64 to 0.84, p? Submitted by:

Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.